Case Studies in CNS Pharmaceutical Research and Development
Identifying responders for a new antipsychotic
Blind prediction of Phase I human volunteer scopolamine Proof-of-Concept trial for novel cognitive enhancer in Alzheimer's Disease
Prediction of Phase II clinical outcome for stand-alone medication with novel target in schizophrenia
Blind prediction of Phase II clinical outcome for new antipsychotic in schizophrenia
General Services